TrialFrontiers in endocrinology2023

Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial.

What the trial testedrandomised · 156 people · 2023

Randomised comparison

+4.55kg+3.43 to +5.67

As reported

difference 4.55 kg, 95% CI 3.43–5.67

the abstract, start to end

… with a between-group difference of 4.55 kg (95% CI, 3.43 to 5.67) ( …

← favours treatmentfavours comparator →

could be chance

Body weight & composition

4.553.43–5.67

MetforminOther glucose-loweringBody weight & composition

1 / 3

2023

2024

2025

2026

this paperpooled ittrialcites it